Niagen Bioscience, Inc. (NAGE) stock
NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3011% below fair value
$2.04+0.03 (+1.49%)
Close on Nov 17, 2026Market cap $161.42MP/E 17.0Yield –
Niagen Bioscience cash
Cash and short-term investments held at the end of each period.
Niagen Bioscience's cash was $69.51M at Sep 30, 2026. For fiscal 2025 it was $64.79M, up 45.1% from the year before. Over ten years it grew 27.9% a year on average. The highest annual figure on record is $64.79M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.79M | +45.1% |
| FY2024 | Dec 31, 2024 | $44.66M | +63.4% |
| FY2023 | Dec 31, 2023 | $27.33M | +33.7% |
| FY2022 | Dec 31, 2022 | $20.44M | -27.6% |
| FY2021 | Dec 31, 2021 | $28.22M | +69.0% |
| FY2020 | Dec 31, 2020 | $16.70M | -11.2% |
| FY2019 | Dec 31, 2019 | $18.81M | -16.8% |
| FY2018 | Dec 31, 2018 | $22.62M | -50.2% |
| FY2017 | Dec 30, 2017 | $45.39M | +2664.3% |
| FY2016 | Dec 31, 2016 | $1.64M | -70.4% |
| FY2015 | Jan 2, 2016 | $5.55M | +40.0% |
| FY2014 | Jan 3, 2015 | $3.96M | +75.3% |
| FY2013 | Dec 28, 2013 | $2.26M | +334.9% |
| FY2012 | Dec 29, 2012 | $520.00K | +23.8% |
| FY2011 | Dec 31, 2011 | $420.15K | -81.1% |
| FY2010 | Jan 1, 2011 | $2.23M | +372.3% |
| FY2009 | Jan 2, 2010 | $471.38K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $69.51M | +8.1% |
| Q2 FY2026 | Jun 30, 2026 | $66.74M | +10.4% |
| Q1 FY2026 | Mar 31, 2026 | $66.55M | +19.7% |
| Q4 FY2025 | Dec 31, 2025 | $64.79M | +45.1% |
| Q3 FY2025 | Sep 30, 2025 | $64.29M | +98.4% |
| Q2 FY2025 | Jun 30, 2025 | $60.47M | +116.9% |
| Q1 FY2025 | Mar 31, 2025 | $55.62M | +101.8% |
| Q4 FY2024 | Dec 31, 2024 | $44.66M | +63.4% |
| Q3 FY2024 | Sep 30, 2024 | $32.40M | +21.0% |
| Q2 FY2024 | Jun 30, 2024 | $27.89M | +5.6% |
| Q1 FY2024 | Mar 31, 2024 | $27.57M | +19.1% |
| Q4 FY2023 | Dec 31, 2023 | $27.33M | +33.7% |
| Q3 FY2023 | Sep 30, 2023 | $26.77M | +101.9% |
| Q2 FY2023 | Jun 30, 2023 | $26.41M | +54.7% |
| Q1 FY2023 | Mar 31, 2023 | $23.14M | +10.2% |
| Q4 FY2022 | Dec 31, 2022 | $20.44M | -27.6% |
| Q3 FY2022 | Sep 30, 2022 | $13.26M | -59.9% |
| Q2 FY2022 | Jun 30, 2022 | $17.07M | -56.0% |
| Q1 FY2022 | Mar 31, 2022 | $20.99M | -53.0% |
| Q4 FY2021 | Dec 31, 2021 | $28.22M | +69.0% |
| Q3 FY2021 | Sep 30, 2021 | $33.10M | +113.9% |
| Q2 FY2021 | Jun 30, 2021 | $38.78M | +105.3% |
| Q1 FY2021 | Mar 31, 2021 | $44.69M | +228.4% |
| Q4 FY2020 | Dec 31, 2020 | $16.70M | -11.2% |
| Q3 FY2020 | Sep 30, 2020 | $15.48M | -18.0% |
| Q2 FY2020 | Jun 30, 2020 | $18.89M | -4.4% |
| Q1 FY2020 | Mar 31, 2020 | $13.61M | -29.6% |
| Q4 FY2019 | Dec 31, 2019 | $18.81M | -16.8% |
| Q3 FY2019 | Sep 30, 2019 | $18.88M | -33.1% |
| Q2 FY2019 | Jun 30, 2019 | $19.76M | -40.8% |
| Q1 FY2019 | Mar 31, 2019 | $19.33M | -52.9% |
| Q4 FY2018 | Dec 31, 2018 | $22.62M | -50.2% |
| Q3 FY2018 | Sep 30, 2018 | $28.21M | +17.6% |
| Q2 FY2018 | Jun 30, 2018 | $33.39M | +136.1% |
| Q1 FY2018 | Mar 31, 2018 | $41.04M | +2399.2% |
| Q4 FY2017 | Dec 30, 2017 | $45.39M | +1904.1% |
| Q3 FY2017 | Sep 30, 2017 | $24.00M | – |
| Q2 FY2017 | Jul 1, 2017 | $14.14M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.64M | – |
| Q3 FY2016 | Oct 1, 2016 | $2.26M | – |
See a number that looks wrong?